Nature Search

Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant

Grigori Okoev
Daniel J. Weisdorf
Mukta Arora
Research08 Jan 2021
Bone Marrow Transplantation

Volume: 56, P: 1373-1380
High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group

Najla El Jurdi
Heba Elhusseini
Mukta Arora
ResearchOpen Access18 May 2021
Blood Cancer Journal

Volume: 11, P: 1-7
Magnetic Force Microscopic Images of Nanometer-Sized Polyradical Particles

Tsuyoshi Michinobu
Jun Inui
Hiroyuki Nishide
Research01 Jan 2003
Polymer Journal

Volume: 35, P: 71-75
Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines

Answer ALS is a resource of patient-derived iPS cell lines, multi-omic data derived from iPS neurons and longitudinal clinical and smartphone data from over 1,000 patients with ALS. This serves as a foundation to identify distinct disease subgroups.

Emily G. Baxi
Terri Thompson
Jeffrey D. Rothstein
ResearchOpen Access03 Feb 2022
Nature Neuroscience

Volume: 25, P: 226-237
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort

F Demichelis
K Fall
M A Rubin
Research22 Jan 2007
Oncogene

Volume: 26, P: 4596-4599
International multicentre study examining selection criteria for active surveillance in men undergoing radical prostatectomy

L-M Wong
D E Neal
N M Corcoran
ResearchOpen Access04 Oct 2012
British Journal of Cancer

Volume: 107, P: 1467-1473
Impact of NADiA ProsVue PSA slope on secondary treatment decisions after radical prostatectomy

J W Moul
D Y T Chen
M A Reynolds
Research15 Jul 2014
Prostate Cancer and Prostatic Diseases

Volume: 17, P: 280-285
Higher therapeutic CsA levels early post transplantation reduce risk of acute GVHD and improves survival

J R Rogosheske
A D Fargen
C G Brunstein
Research16 Sept 2013
Bone Marrow Transplantation

Volume: 49, P: 122-125
Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donors

N S Majhail
C G Brunstein
D J Weisdorf
Research23 May 2011
Bone Marrow Transplantation

Volume: 47, P: 494-498
Novel disease burden assessment predicts allogeneic transplantation outcomes in myelodysplastic syndrome

B J Trottier
Z Sachs
E D Warlick
Research23 Nov 2015
Bone Marrow Transplantation

Volume: 51, P: 199-204
The effect of equine antithymocyte globulin on the outcomes of reduced intensity conditioning for AML

P Hagen
J E Wagner
C G Brunstein
Research22 Sept 2014
Bone Marrow Transplantation

Volume: 49, P: 1498-1504
Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGvHD

F He
E Warlick
D Weisdorf
Research11 Apr 2016
Bone Marrow Transplantation

Volume: 51, P: 1107-1112
Clinical outcomes of AML patients relapsing after matched-related donor and umbilical cord blood transplantation

N Bejanyan
B Oran
C Brunstein
Research02 Jun 2014
Bone Marrow Transplantation

Volume: 49, P: 1029-1035
Erratum: Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML

C Ustun
A C Wiseman
D Weisdorf
Amendments and Corrections06 Nov 2013
Bone Marrow Transplantation

Volume: 48, P: 1488
Importance of conditioning regimen intensity, MRD positivity, and KIR ligand mismatch in UCB transplantation

C Ustun
C Brunstein
D Weisdorf
Correspondence09 Oct 2017
Bone Marrow Transplantation

Volume: 53, P: 97-100
Bortezomib and vorinostat in refractory acute myelogenous leukemia and high-risk myelodysplastic syndromes: produces stable disease but at the cost of high toxicity

E D Warlick
Q Cao
J Miller
Correspondence28 Feb 2013
Leukemia

Volume: 27, P: 1789-1791
Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML

C Ustun
A C Wiseman
D Weisdorf
Research12 Aug 2013
Bone Marrow Transplantation

Volume: 48, P: 1415-1420
Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival

L E Lunde
S Dasaraju
C Ustun
Research13 Jul 2015
Bone Marrow Transplantation

Volume: 50, P: 1432-1437
MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes

H Pourhassan
T DeFor
E D Warlick
Research12 Dec 2016
Bone Marrow Transplantation

Volume: 52, P: 532-538

Search

Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant

High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group

Magnetic Force Microscopic Images of Nanometer-Sized Polyradical Particles

Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort

International multicentre study examining selection criteria for active surveillance in men undergoing radical prostatectomy

Impact of NADiA ProsVue PSA slope on secondary treatment decisions after radical prostatectomy

Higher therapeutic CsA levels early post transplantation reduce risk of acute GVHD and improves survival

Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donors

Novel disease burden assessment predicts allogeneic transplantation outcomes in myelodysplastic syndrome

The effect of equine antithymocyte globulin on the outcomes of reduced intensity conditioning for AML

Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGvHD

Clinical outcomes of AML patients relapsing after matched-related donor and umbilical cord blood transplantation

Erratum: Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML

Importance of conditioning regimen intensity, MRD positivity, and KIR ligand mismatch in UCB transplantation

Bortezomib and vorinostat in refractory acute myelogenous leukemia and high-risk myelodysplastic syndromes: produces stable disease but at the cost of high toxicity

Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML

Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival

MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes

Search

Quick links

Search

Filter By:

Search

Quick links